natgillin/translations-raw huggingface dataset:
amending Directive 98/8/EC of the European Parliament and of the Council to include methyl nonyl ketone as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev metil-nonil-ketona kot aktivne snovi v Prilogo I k Direktivi
That list includes methyl nonyl ketone.
Navedeni seznam vključuje metil-nonil-keton.
Pursuant to Regulation (EC) No 1451/2007, methyl nonyl ketone has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 19, repellents and attractants, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja metil-nonil-ketona glede uporabe v 19. vrsti izdelkov, repelenti in sredstva za privabljanje (atraktanti), kot je opredeljena v Prilogi V k navedeni direktivi.
Spain was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 8 April 2009 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Španija, ki je bila imenovana za državo članico poročevalko, je 8. aprila 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 9 December 2011, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile 9. decembra 2011 ugotovitve pregleda v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
It appears from the evaluations that biocidal products used as repellents and containing methyl nonyl ketone may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Presoje so pokazale, da je za biocidne pripravke, ki se uporabljajo kot repelenti in vsebujejo metil-nonil-keton, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include methyl nonyl ketone in Annex I to that Directive.
Zato je primerno vključiti metil-nonil-keton v Prilogo I k navedeni direktivi.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo te možnosti uporabe oziroma scenarije izpostavljenosti ter tveganja za populacije ljudi in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
The provisions of this Directive should be applied at the same time in all Member States in order to ensure equal treatment on the Union market of biocidal products containing the active substance methyl nonyl ketone and also to facilitate the proper operation of the biocidal products market in general.
Določbe te direktive se morajo uporabljati hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov metil-nonil-keton, na trgu Unije in tudi da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
Member States shall adopt and publish, by 30 April 2013 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. aprila 2013.
They shall apply those provisions from 1 May 2014.
Navedene predpise uporabljajo od 1. maja 2014.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Države članice posredujejo Komisiji besedilo temeljnih določb nacionalne zakonodaje, ki jih sprejmejo na področju, ki ga ureja ta direktiva.
Deadline for compliance with Article 16(3) (except for products containing more than one active substance, for which the deadline to comply with Article 16(3) shall be the one set out in the last of the inclusion decisions relating to its active substances)
Rok za uskladitev s členom 16(3) (razen za pripravke, ki vsebujejo več kot eno aktivno snov, za katere je rok za uskladitev s členom 16(3) enak roku, določenemu v zadnji odločitvi o vključitvi njegovih aktivnih snovi)
methyl nonyl ketone
Metil-nonil-keton
CAS No: 112-12-9
Št. CAS: 112-12-9
EC No: 203-937-5
št. ES: 203-937-5
1 May 2014
maj 2014
30 April 2024
april 2024
The Union level risk assessment was based on indoor use by non-professional users.
Ocena tveganja na ravni Unije je temeljila na uporabi v zaprtem prostoru nepoklicnih uporabnikov.
Commission Directive 2012/15/EU
Direktiva Komisije 2012/15/EU
amending Directive 98/8/EC of the European Parliament and of the Council to include margosa extract as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev margoza ekstrakta kot aktivne snovi v Prilogo I k Direktivi
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market [2] establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
Uredba Komisije (ES) št. 1451/2007 z dne 4. decembra 2007 o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet [2] določa seznam aktivnih snovi, ki se ocenijo glede njihove možne vključitve v priloge I, IA ali IB k Direktivi 98/8/ES.
That list includes margosa extract.
Navedeni seznam vključuje margoza ekstrakt.
Pursuant to Regulation (EC) No 1451/2007, margosa extract has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja margoza ekstrakta glede uporabe v 18. vrsti izdelkov, insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k navedeni direktivi.
The evaluation concerned margosa extract from the kernels of Azadirachta indica extracted with water and further processed with organic solvents.
Presoja se je nanašala na margoza ekstrakt iz jedrc Azadirachta indica, ekstrahiran z vodo in nadalje obdelan z organskimi topili.
Any possible other substances complying with the definition of margosa extract in the list of active substances to be assessed in Regulation (EC) No 1451/2007 have not been evaluated, and should therefore not be included in Annex I to Directive 98/8/EC based on this evaluation.
Za vse druge možne snovi, ki so v skladu z opredelitvijo margoza ekstrakta na seznamu aktivnih snovi, ki jih je treba oceniti v skladu z Uredbo (ES) št. 1451/2007, presoja ni bila opravljena in se zato ne smejo vključiti v Prilogo I k Direktivi 98/8/ES na podlagi te presoje.
Germany was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 26 November 2009 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Nemčija, ki je bila imenovana za državo članico poročevalko, je 26. novembra 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from the evaluations that biocidal products used as insecticides, acaricides and products to control other arthropods and containing margosa extract may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Presoje so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev ter vsebujejo margoza ekstrakt, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include margosa extract in Annex I to that Directive.
Zato je primerno vključiti margoza ekstrakt v Prilogo I k navedeni direktivi.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo te možnosti uporabe oziroma scenarije izpostavljenosti ter tveganja za populacije ljudi in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljive ravni.
In view of the risks identified for surface water, sediment and non-target arthropods, it is appropriate to require that product authorisations are subject to appropriate risk mitigation measures.
Zaradi ugotovljenega tveganja za površinske vode, usedline in neciljne členonožce je primerno, da se zahteva, da se za dovoljenja za pripravke sprejmejo ustrezni ukrepi za zmanjševanje tveganj.
The provisions of this Directive should be applied at the same time in all Member States in order to ensure equal treatment on the Union market of biocidal products containing the active substance margosa extract and also to facilitate the proper operation of the biocidal products market in general.
Določbe te direktive se morajo uporabljati hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov margoza ekstrakt, na trgu Unije in tudi da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
margosa extract
margoza ekstrakt
IUPAC name: Not applicable
Ime po IUPAC: ni relevantno.
CAS-No: 84696-25-3
Št. CAS: 84696-25-3
EC No: 283-644-7
Št. EC: 283-644-7
Description: margosa extract from the kernels of Azadirachta indica extracted with water and further processed with organic solvents
Opis: margoza ekstrakt iz jedrc Azadirachta indica, ekstrahiran z vodo in nadalje obdelan z organskimi topili
1 May 2014
1. maj 2014
30 April 2024
30. april 2024
Member States shall ensure that authorisations are subject to appropriate risk mitigation measures for the protection of surface water, sediment and non-target arthropods.’
Države članice zagotovijo, da se za dovoljenja sprejmejo ustrezni ukrepi za zmanjševanje tveganj za zaščito površinskih voda, usedlin in neciljnih členonožcev.“
Commission Directive 2012/16/EU
Direktiva Komisije 2012/16/EU
amending Directive 98/8/EC of the European Parliament and of the Council to include hydrochloric acid as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev klorovodikove kisline kot aktivne snovi v Prilogo I k Direktivi
That list includes hydrochloric acid.
Navedeni seznam vključuje klorovodikovo kislino.
Pursuant to Regulation (EC) No 1451/2007, hydrochloric acid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 2, private area and public health area disinfectants and other biocidal products, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja klorovodikove kisline glede uporabe v 2. vrsti izdelkov, razkužil in drugih biocidnih pripravkov za zasebne površine in površine, namenjene javnemu zdravstvu, kot je opredeljena v Prilogi V k navedeni direktivi.
Latvia was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 16 October 2009 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Latvija, ki je bila imenovana za državo članico poročevalko, je 16. oktobra 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji predložila poročilo pristojnega organa in priporočilo.
It appears from the evaluations that biocidal products used as private area and public health area disinfectants and other biocidal products, in accordance with the said product-type 2, and containing hydrochloric acid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz ocen je mogoče sklepati, da bi biocidni pripravki, ki se uporabljajo kot razkužila in drugi biocidni pripravki za zasebne površine in površine, namenjene javnemu zdravstvu, v skladu z navedeno 2. vrsto izdelkov in ki vsebujejo klorovodikovo kislino, lahko zadovoljili zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include hydrochloric acid in Annex I to that Directive.
Zato je primerno vključiti klorovodikovo kislino v Prilogo I k navedeni direktivi.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo te možnosti uporabe oziroma scenarije izpostavljenosti ter tveganja za človeške populacije in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljive ravni.
In view of the corrosivity of the substance as well as the possible measures identified to mitigate the related risk, it is appropriate to require that exposure during non-professional use is minimised through the design of the packaging, unless it can be demonstrated in the application for product authorisation that risks for human health can be reduced to acceptable levels by other means.
Glede na jedkost snovi ter možne ukrepe za zmanjšanje s tem povezanega tveganja je primerno zahtevati, da je izpostavljenost med neprofesionalno uporabo minimizirana z oblikovanjem embalaže, razen če je mogoče pri uporabi dovoljenja za pripravek dokazati, da je tveganja za človeško zdravje mogoče zmanjšati na sprejemljive ravni z drugimi sredstvi.
The provisions of this Directive should be applied at the same time in all Member States in order to ensure equal treatment on the Union market of biocidal products containing the active substance hydrochloric acid and also to facilitate the proper operation of the biocidal products market in general.
Določbe te direktive se morajo uporabljati hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov klorovodikovo kislino, na trgu Unije in tudi da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
Member States shall adopt and publish, by 30 April 2013 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone ter druge predpise in določbe, potrebne za uskladitev s to direktivo, najpozneje do 30. aprila 2013.
This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Ta Direktiva začne veljati dvajseti dan po objavi v Uradnem listu Evropske unije.
CAS No: not applicable
Št. CAS: ni relevantno
EC No: 231-595-7
Št. EC: 231-595-7
Member States shall ensure that authorisations of products for non-professional use are subject to the packaging being designed to minimise user exposure, unless it can be demonstrated in the application for product authorisation that risks for human health can be reduced to acceptable levels by other means.’
Države članice zagotovijo, da so dovoljenja za pripravke za neprofesionalno uporabo odvisna od embalaže, ki je oblikovana za zmanjšanje izpostavljenosti uporabnika, razen če je mogoče pri dovoljenju za pripravke dokazati, da je mogoče tveganja za človeško zdravje zmanjšati na sprejemljive ravni z drugimi sredstvi.“
Directive 2012/17/EU of the European Parliament and of the Council
Direktiva 2012/17/EU Evropskega parlamenta in Sveta
amending Council Directive 89/666/EEC and Directives 2005/56/EC and 2009/101/EC of the European Parliament and of the Council as regards the interconnection of central, commercial and companies registers
o spremembi Direktive Sveta 89/666/EGS ter direktiv 2005/56/ES in 2009/101/ES Evropskega parlamenta in Sveta glede povezovanja centralnih in trgovinskih registrov ter registrov družb
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 50 thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti člena 50 Pogodbe,
Businesses are increasingly expanding beyond national borders, using the opportunities offered by the internal market.
Podjetja vse bolj širijo svoje dejavnosti čez nacionalne meje in izkoriščajo priložnosti, ki jih ponuja notranji trg.
Cross-border groups, as well as many restructuring operations, such as mergers and divisions, involve companies from different Member States.
Čezmejne skupine in veliko število prestrukturiranj družb, kot so združitve in delitve, vključujejo družbe iz različnih držav članic.
Consequently, there is an increasing demand for access to information on companies in a cross-border context.
Zato je vse večje povpraševanje po čezmejnem dostopu do informacij o družbah.
However, official information on companies is not always readily available on a cross-border basis.
Vendar čezmejni dostop do uradnih informacij o družbah ni vedno takoj na voljo.
Eleventh Council Directive 89/666/EEC of 21 December 1989 concerning disclosure requirements in respect of branches opened in a Member State by certain types of company governed by the law of another State [3] establishes the list of documents and particulars that companies have to disclose in the register of their branch.
Enajsta Direktiva Sveta 89/666/EGS z dne 21. decembra 1989 o razkritjih podružnic, ki jih v državi članici odprejo nekatere oblike družb, za katere velja zakonodaja druge države [3], vzpostavlja seznam dokumentov in podatkov, ki jih družbe morajo razkriti v registru svoje podružnice.
However, there is no legal obligation on the registers to exchange data concerning foreign branches.
Vendar registri nimajo zakonske obveznosti izmenjavati podatke o tujih podružnicah.
This leads to legal uncertainty for third parties as, despite the striking-off of the company from the register, its branch may continue to operate.
To povzroča pravno negotovost za tretje osebe, saj lahko kljub izbrisu družbe iz registra njena podružnica še naprej deluje.
Operations such as cross-border mergers have made day-to-day cooperation between business registers a necessity.
Zaradi postopkov, kot so čezmejne združitve, je potrebno vsakodnevno sodelovanje med poslovnimi registri.
Directive 2005/56/EC of the European Parliament and of the Council of 26 October 2005 on cross-border mergers of limited liability companies [4] requires the registers to cooperate across borders.
Direktiva 2005/56/ES Evropskega parlamenta in Sveta z dne 26. oktobra 2005 o čezmejnih združitvah kapitalskih družb [4] zahteva čezmejno sodelovanje registrov.
There are, however, no established channels of communication that could accelerate procedures, help overcome language problems, and enhance legal certainty.
Ni pa vzpostavljenih poti za komuniciranje, ki bi lahko pospešile postopke, pomagale premagati jezikovne težave in povečale pravno varnost.
Directive 2009/101/EC of the European Parliament and of the Council of 16 September 2009 on coordination of safeguards which, for the protection of the interests of members and third parties, are required by Member States of companies within the meaning of the second paragraph of Article 54 of the Treaty, with a view to making such safeguards equivalent [5] ensures, inter alia, that documents and particulars stored in the register can be accessed by paper means or by electronic means.
Direktiva 2009/101/ES Evropskega parlamenta in Sveta z dne 16. septembra 2009 o uskladitvi zaščitnih ukrepov za varovanje interesov družbenikov in tretjih oseb, ki jih države članice zahtevajo od gospodarskih družb v skladu z drugim pododstavkom člena 54 Pogodbe, zato da se oblikujejo zaščitni ukrepi z enakim učinkom v vsej Skupnosti [5] med drugim zagotavlja, da so lahko dokumenti in podatki, shranjeni v registru, dostopni v papirni ali elektronski obliki.
However, citizens and companies still need to search the register on a country-by-country basis, in particular because the current voluntary cooperation between registers has not proved to be sufficient.
Vendar morajo državljani in gospodarske družbe še vedno iskati po registrih vsake države posebej, zlasti, ker se je izkazalo, da trenutno prostovoljno sodelovanje med registri ne zadostuje.
The Commission Communication on the Single Market Act identified the interconnection of central, commercial and companies registers as a measure required to create a more business-friendly legal and fiscal environment.
Sporočilo Komisije o aktu za enotni trg je povezovanje centralnih in trgovinskih registrov ter registrov družb opredelilo kot ukrep, ki je potreben za ustvarjanje podjetjem naklonjenega pravnega in fiskalnega okolja.
The interconnection should contribute to fostering the competitiveness of European business by reducing administrative burdens and increasing legal certainty and thus contributing to an exit from the global economic and financial crisis, which is one of the priorities of the agenda Europe 2020.
Povezovanje bi moralo z zmanjševanjem upravnih obremenitev in povečanjem pravne varnosti prispevati k spodbujanju konkurenčnosti evropskega gospodarstva in tako k izhodu iz svetovne ekonomske in finančne krize, kar je ena od prednostnih nalog agende Evropa 2020.
It should also improve cross-border communication between registers by using innovations in information and communication technology.
Z uporabo novosti informacijske in komunikacijske tehnologije bi se morala izboljšati tudi čezmejna komunikacija med registri.
The Council Conclusions of 25 May 2010 on the interconnection of business registers confirmed that improving access to up-to-date and trustworthy information on companies could encourage greater confidence in the market, help recovery, and increase the competitiveness of European business.
Sklepi Sveta z dne 25. maja 2010 o povezovanju poslovnih registrov so potrdili, da bi izboljšanje dostopa do najnovejših in verodostojnih informacij o družbah lahko spodbudilo večje zaupanje v trg ter pomagalo pri okrevanju in povečanju konkurenčnosti evropskega gospodarstva.
The European Parliament in its resolution of 7 September 2010 on the interconnection of business registers [6] emphasised that the usefulness of the project for the further integration of the European Economic Area can only be exploited if all Member States take part in the network.
(7) Evropski parlament je v resoluciji z dne 7. septembra 2010 o povezovanju poslovnih registrov [6] poudaril, da je projekt za nadaljnje povezovanje evropskega gospodarskega prostora uporaben le, če v omrežju sodelujejo vse države članice.